Mark R. Southwood

Cambridge, ENG CB20XY, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Interleukin-6 is critical in the development of pulmonary vascular disease in Gcn2-deficient mice.

Interleukin-6 is critical in the development of pulmonary vascular disease in Gcn2-deficient mice.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: July 06, 2026

BMP9 knockout impairs pulmonary vessel muscularisation and confers aberrant tamoxifen sensitivity.

BMP9 knockout impairs pulmonary vessel muscularisation and confers aberrant tamoxifen sensitivity.

Journal: Angiogenesis

Published: April 01, 2025

Angiopoietin 2 and hsCRP are associated with pulmonary hemodynamics and long-term mortality respectively in CTEPH-Results from a prospective discovery and validation biomarker study.

Angiopoietin 2 and hsCRP are associated with pulmonary hemodynamics and long-term mortality respectively in CTEPH-Results from a prospective discovery and validation biomarker study.

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: November 18, 2021

Circulating BMP9 Protects the Pulmonary Endothelium during Inflammation-induced Lung Injury in Mice.

Circulating BMP9 Protects the Pulmonary Endothelium during Inflammation-induced Lung Injury in Mice.

Journal: American journal of respiratory and critical care medicine

Published: December 15, 2020

Single-cell RNA sequencing profiling of mouse endothelial cells in response to pulmonary arterial hypertension.

Single-cell RNA sequencing profiling of mouse endothelial cells in response to pulmonary arterial hypertension.

Journal: Cardiovascular research

Published: August 17, 2020

Targeting translational read-through of premature termination mutations in BMPR2 with PTC124 for pulmonary arterial hypertension.

Targeting translational read-through of premature termination mutations in BMPR2 with PTC124 for pulmonary arterial hypertension.

Journal: Pulmonary circulation

Published: April 28, 2020

4PBA Restores Signaling of a Cysteine-substituted Mutant BMPR2 Receptor Found in Patients with Pulmonary Arterial Hypertension.

4PBA Restores Signaling of a Cysteine-substituted Mutant BMPR2 Receptor Found in Patients with Pulmonary Arterial Hypertension.

Journal: American journal of respiratory cell and molecular biology

Published: April 08, 2020

Lesson of the month: novel method to quantify neutrophil uptake in early lung cancer using SPECT-CT.

Lesson of the month: novel method to quantify neutrophil uptake in early lung cancer using SPECT-CT.

Journal: Thorax

Published: February 11, 2020

Targeting HIF2α-ARNT hetero-dimerisation as a novel therapeutic strategy for pulmonary arterial hypertension.

Targeting HIF2α-ARNT hetero-dimerisation as a novel therapeutic strategy for pulmonary arterial hypertension.

Journal: The European respiratory journal

Published: October 22, 2019

ACTRIIA-Fc rebalances activin/GDF versus BMP signaling in pulmonary hypertension.

ACTRIIA-Fc rebalances activin/GDF versus BMP signaling in pulmonary hypertension.

Journal: Science translational medicine

Published: September 19, 2019

Systematic evaluation of PAXgene® tissue fixation for the histopathological and molecular study of lung cancer.

Systematic evaluation of PAXgene® tissue fixation for the histopathological and molecular study of lung cancer.

Journal: The journal of pathology. Clinical research

Published: July 10, 2019

The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension.

The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension.

Journal: The European respiratory journal

Published: September 22, 2018

Showing 1-12 of 46

Last Updated: 09/26/2026